Financial reports
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
24 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
18 Mar 22
10-Q
2021 Q3
Quarterly report
29 Nov 21
Current reports
8-K
MiNK Reports Fourth Quarter and Year-End 2023 Results
21 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
MiNK Therapeutics Reports Third Quarter 2023 Results
9 Nov 23
8-K
Departure of Directors or Certain Officers
17 Oct 23
8-K
MiNK Therapeutics Reports Second Quarter 2023 Results
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
8-K
MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
11 May 23
8-K
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
21 Mar 23
8-K
MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results
3 Nov 22
Registration and prospectus
S-8
Registration of securities for employees
11 Aug 23
S-3
Shelf registration
3 Nov 22
S-8
Registration of securities for employees
15 Jul 22
424B4
Prospectus supplement with pricing info
15 Oct 21
FWP
Free writing prospectus
15 Oct 21
8-A12B
Registration of securities on exchange
13 Oct 21
S-1/A
IPO registration (amended)
12 Oct 21
S-1
IPO registration
13 Sep 21
DRS/A
Draft registration statement (amended)
28 Jul 21
DRSLTR
Correspondence regarding draft registration statement
28 Jul 21
Proxies
Other
EFFECT
Notice of effectiveness
9 Nov 22
CORRESP
Correspondence with SEC
7 Nov 22
UPLOAD
Letter from SEC
7 Nov 22
EFFECT
Notice of effectiveness
15 Oct 21
CERT
Certification of approval for exchange listing
14 Oct 21
CORRESP
Correspondence with SEC
12 Oct 21
CORRESP
Correspondence with SEC
12 Oct 21
CORRESP
Correspondence with SEC
24 Sep 21
CORRESP
Correspondence with SEC
13 Sep 21
UPLOAD
Letter from SEC
12 Aug 21